Related Experiment Video
Updated: Oct 30, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
CUT Domain Proteins in DNA Repair and Cancer
Zubaidah M Ramdzan1, Elise Vickridge1, Camila C F Faraco1,2
1Goodman Cancer Research Centre, McGill University, 1160 Pine Avenue West, Montreal, QC H3A 1A3, Canada.
CUT domain proteins accelerate DNA repair and are exploited by cancer cells for survival. Inhibiting these proteins is synthetic lethal in cancer cells with high reactive oxygen species (ROS) levels.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- CUT domain proteins are accessory factors that enhance DNA repair enzyme activity.
- Cancer cells with activated RAS pathways generate excess reactive oxygen species (ROS), leading to oxidative DNA damage.
- Elevated expression of CUT domain proteins like CUX1, CUX2, and SATB1 aids cancer cell adaptation and survival by boosting DNA repair capacity.
Purpose of the Study:
- To investigate the role of CUT domain proteins in DNA repair and cancer cell survival.
- To explore the synthetic lethality of targeting CUT domain proteins in specific cancer contexts.
- To understand how CUT domain protein overexpression confers resistance to genotoxic treatments.
Main Methods:
- Studied the enzymatic activities of base excision repair enzymes (OGG1, APE1, DNA pol β) with CUT domain proteins.
- Analyzed the effect of RAS pathway activation on ROS levels and DNA damage in cancer cells.
- Investigated the impact of CUX1, CUX2, and SATB1 knockdown on cancer cell viability with high ROS levels.
- Assessed the resistance of CUT domain protein-overexpressing cancer cells to genotoxic agents.
Main Results:
- CUT domains were shown to stimulate the activity of key base excision repair enzymes.
- Overexpression of CUX1 cooperated with RAS in promoting mammary and lung tumor formation in mice.
- Knockdown of CUX1, CUX2, or SATB1 exhibited synthetic lethality in cancer cells with mutations in KRAS, HRAS, BRAF, or EGFR.
- Cancer cells overexpressing CUT domain proteins demonstrated increased resistance to ionizing radiation, temozolomide, and cisplatin.
Conclusions:
- CUT domain proteins play a critical role in DNA repair and cancer cell adaptation.
- Targeting CUT domain proteins represents a potential therapeutic strategy for cancers with high ROS levels and specific mutations.
- Understanding CUT domain protein function provides insights into cancer resistance mechanisms to genotoxic therapies.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Overview of DNA Repair
Chemically...
Overview of DNA Repair
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

